
|Articles|September 27, 2004
New help available for neonatal jaundice
Pediatricians have so much faith in a drug for treating neonatal hyperbilirubinemia that even though it hasn't been approved by the Food & Drug Administration yet, they are recommending its use in their just-released guidelines.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Accepts Sandoz Applications for Generic Tirzepatide
2
Advocacy in Action: How Community Pharmacists Can Drive Change
3
Tech-Driven Home Pharmacy Model Tackles Rural Health Crises
4
Same-Day COVID-19, Influenza Vaccination Does Not Increase Adverse Events
5































